SEC Form 4 · accession 0001209191-15-019706
Sesen Bio, Inc. · SESN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Steven Furfine
Officer — Chief Science Officer
Period of report
Feb 26, 2015
Accepted (ET)
Feb 27, 2015 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001485003
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $10.39 | Feb 26, 2015 | A | 52,500 | A | — | Feb 25, 2025 | Common Stock | 52,500 | 217,854 | D |
Explanation of responses
- F1This option was granted on February 26, 2015 and vests over four years in equal quarterly installments, with the first installment vesting on March 31, 2015.